Found: 21
Select item for more details and to access through your institution.
PD‐L1 expression is associated with the spontaneous regression of patients with methotrexate‐associated lymphoproliferative disorders.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 417, doi. 10.1002/cam4.4462
- By:
- Publication type:
- Article
Prognostic factors to predict the survival in patients with advanced gastric cancer who receive later‐line nivolumab monotherapy—The Asahikawa Gastric Cancer Cohort Study (AGCC).
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 406, doi. 10.1002/cam4.4461
- By:
- Publication type:
- Article
A screening assistance system for cervical cytology of squamous cell atypia based on a two‐step combined CNN algorithm with label smoothing.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 520, doi. 10.1002/cam4.4460
- By:
- Publication type:
- Article
Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 530, doi. 10.1002/cam4.4459
- By:
- Publication type:
- Article
Construction and validation of a prognostic nomogram for anal squamous cell carcinoma.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 392, doi. 10.1002/cam4.4458
- By:
- Publication type:
- Article
Cancer‐associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 492, doi. 10.1002/cam4.4452
- By:
- Publication type:
- Article
Examining the association between oncology drug clinical benefit and the time to public reimbursement.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 380, doi. 10.1002/cam4.4455
- By:
- Publication type:
- Article
Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open‐label phase 2 study.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 371, doi. 10.1002/cam4.4454
- By:
- Publication type:
- Article
The prognostic value of TPM1–4 in hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 433, doi. 10.1002/cam4.4453
- By:
- Publication type:
- Article
Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000–2015: Population‐based analysis.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 507, doi. 10.1002/cam4.4457
- By:
- Publication type:
- Article
Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 358, doi. 10.1002/cam4.4451
- By:
- Publication type:
- Article
Better effect of intrapleural perfusion with hyperthermic chemotherapy by video‐assisted thoracoscopic surgery for malignant pleural effusion treatment compared to normothermic chemoperfusion of the pleural cavity.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 348, doi. 10.1002/cam4.4450
- By:
- Publication type:
- Article
What if the future of HER2‐positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 332, doi. 10.1002/cam4.4449
- By:
- Publication type:
- Article
Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 317, doi. 10.1002/cam4.4448
- By:
- Publication type:
- Article
Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 447, doi. 10.1002/cam4.4447
- By:
- Publication type:
- Article
Phase 1 trial of ADI‐PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 340, doi. 10.1002/cam4.4446
- By:
- Publication type:
- Article
B7‐1 and programmed cell death‐ligand 1 in primary and lymph node metastasis lesions of non‐small cell lung carcinoma.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 479, doi. 10.1002/cam4.4444
- By:
- Publication type:
- Article
Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 539, doi. 10.1002/cam4.4443
- By:
- Publication type:
- Article
Muscle weakness as an additional criterion for grading sarcopenia‐related prognosis in patients with cancer.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 308, doi. 10.1002/cam4.4362
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 295, doi. 10.1002/cam4.3989
- Publication type:
- Article
Simulation modeling of breast cancer endocrine therapy duration by patient and tumor characteristics.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 297, doi. 10.1002/cam4.4084
- By:
- Publication type:
- Article